BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32193900)

  • 1. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.
    Park GC; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Yoon YI; Cho HD; Kwon JH; Chung YK; Kang SH; Choi JU; Jung IJ; Lee SG
    J Korean Med Sci; 2020 Mar; 35(11):e69. PubMed ID: 32193900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Malignancy After Adult-to-Adult Living Donor Liver Transplantation: A Single-Center Long-Term Experience.
    Masuda Y; Mita A; Ohno Y; Kubota K; Notake T; Shimizu A; Soejima Y
    Transplant Proc; 2023 May; 55(4):952-955. PubMed ID: 37088616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy After Living Donor Liver Transplantation.
    Kobayashi T; Miura K; Ishikawa H; Sakata J; Takizawa K; Hirose Y; Toge K; Saito S; Abe S; Kawachi Y; Ichikawa H; Shimada Y; Takahashi Y; Wakai T; Kinoshita Y
    Transplant Proc; 2024 Apr; 56(3):660-666. PubMed ID: 38519268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcomes of extrahepatic malignancy incidentally diagnosed during pretransplant evaluation for living donor liver transplantation.
    Park GC; Hwang S; Song GW; Jung DH; Moon DB; Ahn CS; Kim KH; Ha TY; Yoon YI; Lee SG
    J Hepatobiliary Pancreat Sci; 2020 Apr; 27(4):200-210. PubMed ID: 31957982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk Factor of Hepatocellular Carcinoma Recurrence After Liver Transplant: Results From a Single Clinic.
    Bolkvadze R; Kashibadze K; Nakashidze M; Mikeladze L; Beridze D; Beridze S
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):256-262. PubMed ID: 38385408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic Malignancies and Liver Transplantation: Current Status.
    Choudhary NS; Saigal S; Saraf N; Soin AS
    J Clin Exp Hepatol; 2021; 11(4):494-500. PubMed ID: 34276155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
    Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
    Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.
    Mizuno S; Hayasaki A; Ito T; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2018 Nov; 50(9):2699-2704. PubMed ID: 30401380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study.
    Shalaby S; Taborelli M; Zanetto A; Ferrarese A; D'Arcangelo F; Gambato M; Senzolo M; Russo FP; Germani G; Boccagni P; Ettorre GM; Baccarani U; Lauro A; Galatioto L; Rendina M; Petrara R; De Rossi A; Nudo F; Toti L; Fantola G; Vennarecci G; Risaliti A; Pinna AD; Gruttadauria S; Di Leo A; Rossi M; Tisone G; Zamboni F; Cillo U; Piselli P; Serraino D; Burra P;
    Transpl Int; 2021 Apr; 34(4):743-753. PubMed ID: 33492715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
    Kim SH; Lee EC; Na BG; Park SJ
    Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry.
    Park HW; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Namgoong JM; Yoon SY; Park CS; Park YH; Lee HJ; Lee SG
    Transplant Proc; 2012 Apr; 44(3):802-5. PubMed ID: 22483500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of living donor liver transplantation in patients with a prior history of nonhepatic malignancy.
    Yamamoto H; Sambommatsu Y; Ibuki S; Shimata K; Sugawara Y; Hibi T
    Biosci Trends; 2020 Mar; 14(1):42-47. PubMed ID: 32023575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.
    Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T
    Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.